Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Collegium Pharmaceutical (COLL) Return on Invested Capital (2020 - 2025)

Collegium Pharmaceutical (COLL) has 6 years of Return on Invested Capital data on record, last reported at 0.3% in Q3 2025.

  • For Q3 2025, Return on Invested Capital fell 16.0% year-over-year to 0.3%; the TTM value through Sep 2025 reached 0.3%, down 16.0%, while the annual FY2024 figure was 0.51%, N/A changed from the prior year.
  • Return on Invested Capital reached 0.3% in Q3 2025 per COLL's latest filing, down from 0.46% in the prior quarter.
  • Across five years, Return on Invested Capital topped out at 0.48% in Q2 2023 and bottomed at 1.05% in Q4 2021.
  • Average Return on Invested Capital over 5 years is 0.16%, with a median of 0.21% recorded in 2021.
  • Peak YoY movement for Return on Invested Capital: tumbled -121bps in 2021, then soared 110bps in 2022.
  • A 5-year view of Return on Invested Capital shows it stood at 1.05% in 2021, then surged by 105bps to 0.05% in 2022, then skyrocketed by 200bps to 0.16% in 2023, then surged by 197bps to 0.46% in 2024, then crashed by -36bps to 0.3% in 2025.
  • Per Business Quant database, its latest 3 readings for Return on Invested Capital were 0.3% in Q3 2025, 0.46% in Q4 2024, and 0.45% in Q3 2024.